Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Akero Therapeutics, Inc. | a2242026zex-5_1.htm |
| EX-1.1 - EX-1.1 - Akero Therapeutics, Inc. | a2242026zex-1_1.htm |
| S-1 - S-1 - Akero Therapeutics, Inc. | a2242026zs-1.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated March 16, 2020, relating to the consolidated financial statements of Akero Therapeutics, Inc. appearing in the Annual Report on Form 10-K of Akero Therapeutics, Inc. for the year ended December 31, 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Parsippany, NJ
July 6, 2020